Imricor Medical Systems Inc

Imricor Medical Systems Inc

IMR · AU · Healthcare / Medical Devices

1.31AUD-0.02 (-1.50%)

Price History

Full chart

Market Stats

Previous Close1.33
Open1.38
Day Range1.29 – 1.42
52-Week Range1.28 – 2.25
Volume779.84K
Market Cap539.61M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.12
Dividend Yield0.00%
Beta0.48
50-Day Avg1.87
200-Day Avg1.87

About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Steven Wedan
  • Employees0
  • Headquarters400 Gateway Boulevard, Burnsville, MN, United States, 55337, Australia
  • Websitehttps://www.imricor.com

Leadership

  • Mr. Steven WedanPresident, CEO & Executive Chairman · b. 1969
  • Mr. Jonathon GutCFO & VP of Finance · b. 1986
  • Mr. Vic FabanoVice President of Operations · b. 1962
  • Mr. Greg EnglehardtVice President of Global Sales
  • Mr. Nick TwohyVice President of Marketing & Business Development
  • Mr. Zheng LiCompany Secretary

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue703.92K565.60K1.34M639.70K702.16K696.27K816.01K615.57K959.42K302.50K
Growth (%)--19.65%+137.37%-52.35%+9.76%-0.84%+17.20%-24.56%+55.86%-68.47%
Cost of Revenue214.94K0-377.37K1.10M2.59M2.34M1.73M1.88M2.41M
Gross Profit488.98K565.60K1.34M262.34K-397.67K-1.90M-1.53M-1.12M-924.12K-2.10M
Gross Margin69.47%100.00%100.00%41.01%-56.64%-272.30%-187.10%-181.27%-96.32%-695.68%
Operating Expense5.94M7.11M7.79M12.27M11.22M18.36M15.65M15.74M15.37M21.48M
Operating Income-5.45M-6.54M-6.45M-12.01M-11.62M-20.26M-17.18M-16.86M-16.30M-23.59M
Operating Margin-774.20%-1156.95%-480.55%-1876.80%-1654.57%-2909.72%-2105.16%-2738.12%-1698.60%-7796.89%
EBITDA-5.30M-6.41M-6.12M-11.75M-11.09M-19.57M-16.47M-21.87M-15.55M-22.56M
EBITDA Margin-753.50%-1134.16%-456.00%-1836.58%-1579.36%-2810.74%-2017.85%-3552.88%-1620.62%-7456.40%
Net Income-5.49M-6.71M-7.30M-14.80M-13.08M-20.56M-17.53M-22.63M-29.69M-26.20M
Net Income Margin-780.61%-1186.48%-543.52%-2313.28%-1862.37%-2952.33%-2148.77%-3675.61%-3094.86%-8661.59%
R&D3.93M4.89M4.72M3.60M5.55M9.68M7.95M7.92M8.18M11.54M
R&D as % of Total Revenue558.30%864.46%351.76%562.95%789.89%1389.62%973.78%1286.55%852.61%3816.44%
Interest Expense43.15K164.68K1.07M1.03M300.64K108.85K177.92K47.95K20.07K4.31K
Interest Expense % of Total Revenue6.13%29.12%79.78%161.13%42.82%15.63%21.80%7.79%2.09%1.43%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.47M3.00M16.06M10.52M33.57M26.86M13.70M8.31M21.62M45.79M
Total Liabilities7.50M8.25M2.59M3.49M4.75M4.46M6.19M17.06M29.00M34.26M
Total Equity-4.03M-5.25M13.47M7.03M28.82M22.40M7.51M-12.83M-7.38M11.53M
Cash2.89M2.26M12.44M5.05M25.14M18.52M5.69M831.52K15.71M19.52M
Total Debt2.28M2.99M9.93M1.27M1.39M1.74M4.45M10.42M21.35M25.97M
Net Debt-603.55K725.78K-10.73M-4.89M-23.75M-16.78M-1.24M9.59M5.64M6.45M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.05M-5.65M-6.34M-6.63M-12.23M-17.49M-16.51M-12.98M-15.57M-19.75M
Investing Cash Flow-62.52K-30.55K-201.69K-529.34K-774.03K-695.30K-238.86K-82.78K-74.98K-22.47M
Financing Cash Flow2.16M5.26M6.30M10.45M33.02M11.59M3.94M8.21M30.33M44.55M
Capital Expenditure62.52K30.55K196.52K364.76K741.89K625.75K238.86K82.78K77.98K449.43K
Free Cash Flow-4.11M-5.68M-6.54M-6.99M-12.97M-18.11M-17.06M-13.06M-15.65M-20.20M
FCF to OCF101.54%100.54%103.10%105.50%106.07%103.58%103.33%100.64%100.50%102.28%

Earnings

Report DateFeb 26, 2025Aug 25, 2025
EPS Estimate0.000.00
EPS Actual-0.04-0.04
Surprise--
Timing--

Key Statistics & Ratios

Market Cap539.61M
Enterprise Value616.69M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4493.84
Price / Book17.45
EPS-0.12
Book Value0.1169
Revenue (TTM)120.08K
Gross Profit (TTM)-2.79M
EBITDA-26.65M
Profit Margin0.00%
Operating Margin-12266.37%
Return on Equity-143.12%
Return on Assets-26.53%
Shares Outstanding358.54M
Shares Float308.44M
Beta0.48
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%